Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARgamma to Regulate Cholesterol Efflux and Endothelial Cell Inflammation.
Wang M, Xiang Q, Sun W, Zhang H, Shi R, Guo J, Tong H, Fan M, Ding Y, Shi H, Yu P, Shen L, Wang Q, Chen X.
Wang M, et al.
Oxid Med Cell Longev. 2022 Dec 5;2022:2226168. doi: 10.1155/2022/2226168. eCollection 2022.
Oxid Med Cell Longev. 2022.
PMID: 36518993
Free PMC article.
However, the use of PPARgamma agonist in clinical practice is greatly limited as it could lead to water and sodium retention and hence result in congestive heart failure. Qihuang Zhuyu Formula (QHZYF) is a hospital preparation of Jiangsu Province Hospital of Chinese Medici …
However, the use of PPARgamma agonist in clinical practice is greatly limited as it could lead to water and sodium retention and hence resul …